<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03989882</url>
  </required_header>
  <id_info>
    <org_study_id>HS1888</org_study_id>
    <nct_id>NCT03989882</nct_id>
  </id_info>
  <brief_title>Wheat Germ Supplementation Will Improve Markers of Gut Health, Inflammation, and Insulin Resistance in Overweight Adults</brief_title>
  <official_title>Wheat Germ Supplementation Will Improve Markers of Gut Health, Inflammation, and Insulin Resistance in Overweight Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oklahoma State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oklahoma State University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot study is to determine the effects of wheat germ (WG)&#xD;
      supplementation on gut health and subsequent effects on markers of inflammation and insulin&#xD;
      resistance in overweight individuals. WG is a by-product of wheat processing and an excellent&#xD;
      source of omega-3 fatty acids, vitamin E, and fiber. A few studies have shown the health&#xD;
      benefits of WG including gut modulatory potential, but the prebiotic functions of WG in&#xD;
      humans remain in question and warrant further investigation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Healthy overweight (body mass index, BMI, between 25.0 - 30 kg/m2) between 18 to 45 years old&#xD;
      regardless of gender will be recruited. They will be randomly assigned to receive two energy&#xD;
      balls containing 30 grams of wheat germ or corn meal (control) in a 4-wk randomized&#xD;
      controlled pilot trial. The energy balls will contain wheat germ or corn meal, peanut butter,&#xD;
      honey and milk. Participants will be asked to consume two energy balls daily for 4 weeks.&#xD;
      Anthropometric measures, questionnaires (medical, diet, physical activity and bowel habits),&#xD;
      blood and fecal samples will be collected at baseline and at the end of the four week study.&#xD;
      The investigator's primary outcome variables will be changes in fecal bacteria,&#xD;
      immunoglobulin A, zonulin and short chain fatty acids while secondary outcome variables will&#xD;
      be alterations in plasma markers of inflammation and insulin resistance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 28, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will not know their treatment assignment and energy balls will be in an opaque container.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal bacteria population</measure>
    <time_frame>Change from baseline fecal bacteria at 30 days</time_frame>
    <description>analyzed by 16sRNA sequencing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal immunoglobulin A</measure>
    <time_frame>Change from baseline fecal immunoglobulin A at 30 days</time_frame>
    <description>analyzed by enzyme-linked immunoassay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal zonulin</measure>
    <time_frame>Change from baseline fecal zonulin at 30 days</time_frame>
    <description>analyzed by enzyme-linked immunoassay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal short chain fatty acids</measure>
    <time_frame>Change from baseline fecal shortchain fatty acids at 30 days</time_frame>
    <description>analyzed by gas chromatography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>Change from baselineblood glucose at 30 days</time_frame>
    <description>analyzed using clinical chemistry analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood glycated hemoglobin</measure>
    <time_frame>Change from baseline blood glycated hemoglobin at 30 days</time_frame>
    <description>analyzed using clinical chemistry analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood high sensitivity C-reactive protein</measure>
    <time_frame>Change from baseline blood high sensitivity C-reactive protein at 30 days</time_frame>
    <description>analyzed using clinical chemistry analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood insulin level</measure>
    <time_frame>Change from baselineblood insulin level at 30 days</time_frame>
    <description>analyzed by enzyme-linked immunoassay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Overweight</condition>
  <condition>Insulin Resistance</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Wheat germ</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wheat germ energy balls containing 30 g of wheat germ, peanut butter, and honey to form 2 energy balls that is approximately 200 kcal. Two energy balls will be consumed daily for 30 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control energy ball containing 30 g of cornmeal, peanut butter, and honey to form 2 energy balls that is approximately 200 kcal. Two energy balls will be consumed daily for 30 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wheat germ energy ball</intervention_name>
    <description>wheat germ mixed other ingredients to make an energy ball</description>
    <arm_group_label>Wheat germ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>corresponding control without wheat germ</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Healthy overweight (body mass index, BMI, between 25.0 - 30 kg/m2) 18-45 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        diagnosed diabetes, heart disease, and cancer tobacco use excessive alcohol use taking&#xD;
        mega-doses of antioxidant/vitamin supplements or medications that could interfere with&#xD;
        study endpoints such as antibiotics, anti-inflammatory, and glucose-lowering medications&#xD;
        major surgery occurring within 6 months pregnant or lactating previous high intake of wheat&#xD;
        germ or sensitivity to gluten and wheat products.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edralin Lucas, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Okklahoma State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nutritional Sciences Department, Oklahoma State University</name>
      <address>
        <city>Stillwater</city>
        <state>Oklahoma</state>
        <zip>74078</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 22, 2019</study_first_submitted>
  <study_first_submitted_qc>June 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2019</study_first_posted>
  <last_update_submitted>November 10, 2020</last_update_submitted>
  <last_update_submitted_qc>November 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wheat germ</keyword>
  <keyword>overweight</keyword>
  <keyword>gut microbiome</keyword>
  <keyword>inflammation</keyword>
  <keyword>insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

